Lilly issues Complete Response Letter for Sintilimab in combination with Pemetrexed and Platinum chemotherapy for NSCLC treatment Read more
Innovent and Eli Lilly announce final clinical results and biomarker analysis of phase-Ib study of Sintilimab injection plus Bevacizumab biosimilar injection Read more